{
    "ticker": "SPE.PRC",
    "name": "Spectrum Pharmaceuticals, Inc.",
    "description": "Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative and targeted oncology therapies. Founded in 2001 and headquartered in Henderson, Nevada, Spectrum is dedicated to addressing unmet medical needs in the field of oncology, particularly for patients suffering from hematologic malignancies and solid tumors. The company's portfolio includes several FDA-approved therapies, such as ROLONTIS (eflapegrastim), which is designed to reduce the incidence of neutropenia, and TAZVERIK (tazemetostat), a first-in-class EZH2 inhibitor for the treatment of epithelioid sarcoma and other hematologic cancers. Spectrum is committed to advancing the field of cancer treatment through rigorous clinical trials and research initiatives, with a focus on developing therapies that improve patient outcomes and quality of life. The company is also actively pursuing collaborations and partnerships to enhance its pipeline and expand access to its therapies. With a strong emphasis on innovation and patient-centric care, Spectrum Pharmaceuticals aims to be at the forefront of the fight against cancer.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Henderson, Nevada, USA",
    "founded": "2001",
    "website": "https://www.spectrumpharma.com",
    "ceo": "Joe Turgeon",
    "social_media": {
        "twitter": "https://twitter.com/SpectrumPharma",
        "linkedin": "https://www.linkedin.com/company/spectrum-pharmaceuticals/"
    },
    "investor_relations": "https://investors.spectrumpharma.com",
    "key_executives": [
        {
            "name": "Joe Turgeon",
            "position": "CEO"
        },
        {
            "name": "Khalid Islam",
            "position": "Chairman"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology Therapies",
            "products": [
                "ROLONTIS",
                "TAZVERIK"
            ]
        }
    ],
    "seo": {
        "meta_title": "Spectrum Pharmaceuticals, Inc. | Innovative Oncology Therapies",
        "meta_description": "Explore Spectrum Pharmaceuticals, Inc., a leading biopharmaceutical company dedicated to developing innovative oncology therapies for patients with cancer.",
        "keywords": [
            "Spectrum Pharmaceuticals",
            "Biotechnology",
            "Oncology",
            "Cancer Treatment",
            "ROLONTIS",
            "TAZVERIK"
        ]
    },
    "faq": [
        {
            "question": "What does Spectrum Pharmaceuticals specialize in?",
            "answer": "Spectrum Pharmaceuticals specializes in the development of innovative oncology therapies."
        },
        {
            "question": "Who is the CEO of Spectrum Pharmaceuticals?",
            "answer": "Joe Turgeon is the CEO of Spectrum Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Spectrum Pharmaceuticals headquartered?",
            "answer": "Spectrum Pharmaceuticals is headquartered in Henderson, Nevada, USA."
        },
        {
            "question": "What are Spectrum's main products?",
            "answer": "Spectrum's main products include ROLONTIS and TAZVERIK."
        },
        {
            "question": "When was Spectrum Pharmaceuticals founded?",
            "answer": "Spectrum Pharmaceuticals was founded in 2001."
        }
    ],
    "competitors": [
        "AMGN",
        "NVS",
        "GILD",
        "BMY"
    ],
    "related_stocks": [
        "ABBV",
        "VRTX",
        "REGN",
        "MRK"
    ]
}